Literature DB >> 9601086

Structure and topography of the membrane-binding C2 domain of factor VIII in the presence of dodecylphosphocholine micelles.

S Veeraraghavan1, J D Baleja, G E Gilbert.   

Abstract

A 21 residue peptide from the C2 domain of the antihaemophilic factor VIII competes with factor VIII for membrane-binding sites in vitro. Here, we provide the structure and topography of the peptide in solution, on dodecylphosphocholine (DPC) micelles, determined using 1H-NMR spectroscopy. The peptide assumes an amphipathic structure comprising an extended N-terminal region and a C-terminal helix. The average root-mean-square deviation is 0.7+/-0.2 A for the superimposition of the backbone atoms of Ile6 to Arg18 on the lowest energy structure. Whereas the backbone conformation is similar to that in SDS micelles, the Trp11 side-chain orientation is dramatically changed. The indole ring is nearly parallel to the peptide backbone in SDS micelles but perpendicular in DPC micelles. Further, pKa values of the two histidines change by more than 1 pH unit in SDS relative to DPC, which localizes the imidazole rings to the interfacial region. Line-broadening induced by spin-labelled phosphatidylcholine shows that most of the amino acid side-chains that penetrate the DPC micelle are hydrophobic. Thus, the long axis of the peptide lies parallel to the micelle surface and the hydrophobic face of the alpha-helix provides hydrophobic membrane interaction. The large chemical shift changes shown by Trp11 and N-terminal amino acid residues in SDS relative to DPC indicate that this region may be involved in membrane phospholipid recognition. 1H-NMR assignments, CD spectra, one-dimensional 1H-NMR spectra, chemical-shift analysis and nuclear Overhauser effect information are reported in Supplementary Publication SUP 50184 (11 pages), which has been deposited at the British Library Document Supply Centre, Boston Spa, Wetherby, West Yorkshire LS23 7BQ, U.K, from whom copies can be obtained according to the terms indicated in Biochem. J. (1997) 321, 8.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601086      PMCID: PMC1219512          DOI: 10.1042/bj3320549

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  The interaction of beta-amyloid protein fragment (12-28) with lipid environments.

Authors:  T G Fletcher; D A Keire
Journal:  Protein Sci       Date:  1997-03       Impact factor: 6.725

2.  Backbone dynamics of the major coat protein of bacteriophage M13 in detergent micelles by 15N nuclear magnetic resonance relaxation measurements using the model-free approach and reduced spectral density mapping.

Authors:  C H Papavoine; M L Remerowski; L M Horstink; R N Konings; C W Hilbers; F J van de Ven
Journal:  Biochemistry       Date:  1997-04-01       Impact factor: 3.162

3.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes.

Authors:  J W Ponder; F M Richards
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

4.  NMR studies of the influence of dodecyl sulfate on the amide hydrogen exchange kinetics of a micelle-solubilized hydrophobic tripeptide.

Authors:  J D O'Neil; B D Sykes
Journal:  Biochemistry       Date:  1989-01-24       Impact factor: 3.162

Review 5.  The molecular basis of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

6.  The conformation of substance P in lipid environments.

Authors:  D A Keire; T G Fletcher
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

7.  Physicochemical characterization of dodecylphosphocholine/palmitoyllysophosphatidic acid/myelin basic protein complexes.

Authors:  G L Mendz; D J Miller; I M Jamie; J W White; L R Brown; G B Ralston; I J Kaplin
Journal:  Biochemistry       Date:  1991-07-02       Impact factor: 3.162

8.  Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX.

Authors:  S J Freedman; M D Blostein; J D Baleja; M Jacobs; B C Furie; B Furie
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

9.  A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.

Authors:  M Shima; D Scandella; A Yoshioka; H Nakai; I Tanaka; S Kamisue; S Terada; H Fukui
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

10.  Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine.

Authors:  G E Gilbert; D Drinkwater
Journal:  Biochemistry       Date:  1993-09-21       Impact factor: 3.162

View more
  2 in total

1.  Membrane-binding properties of the Factor VIII C2 domain.

Authors:  Valerie A Novakovic; David B Cullinan; Hironao Wakabayashi; Philip J Fay; James D Baleja; Gary E Gilbert
Journal:  Biochem J       Date:  2011-04-01       Impact factor: 3.857

2.  Unique helical conformation of the fourth cytoplasmic loop of the CB1 cannabinoid receptor in a negatively charged environment.

Authors:  Christy R R Grace; Sudha M Cowsik; Joong-Youn Shim; William J Welsh; Allyn C Howlett
Journal:  J Struct Biol       Date:  2007-04-20       Impact factor: 2.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.